Cadila completes Phase 2 trial for Covid-19 with Hepatitis C drug

Cadila completes Phase 2 trial for Covid-19 with Hepatitis C drug

The company is already working on a Covid-19 vaccine and is in the process of commencing Phase 3 trials by the end of the calendar year.
Check the source here –Source, Financial Express.

Leave your comment
Comment
Name
Email
Change Language